Illinois · House Bill 3256 · 103rd General Assembly

AFFORDABLE DRUG MANUFACTURING

HB 3256 Sponsored by Jenn Ladisch Douglass Died in committee

  1. Introduced Feb 16, 2023
  2. In committee Feb 17, 2023
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

Creates the Affordable Drug Manufacturing Act. Provides that the Department of Public Health shall enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs. Requires the partnerships to result…

Read the full title (216 words)

Creates the Affordable Drug Manufacturing Act. Provides that the Department of Public Health shall enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs. Requires the partnerships to result in the production or distribution of generic prescription drugs with the intent that these drugs be made widely available to public and private purchasers, providers and suppliers, and pharmacies. Provides that the Department shall comply with specified requirements when entering into partnerships or setting prices for generic prescription drugs. Requires the Department to submit separate reports to the General Assembly that: (1) assess the feasibility of directly manufacturing generic prescription drugs and selling generic prescription drugs at a fair price; and (2) describe the status of all drugs targeted under the Act and analyze how the activities of the Department may impact competition, access to targeted drugs, the costs of those drugs, and the costs of generic prescription drugs to public and private purchasers. Contains other provisions. Amends the Freedom of Information Act to exempt certain information disclosed under the Affordable Drug Manufacturing Act from inspection and copying. Contains a severability provision. Effective July 1, 2023.

Every action

11 steps, oldest first, as the legislature records them.

  1. HouseFiled with the Clerk by Rep. Nabeela Syed
  2. HouseFirst Reading
  3. CommitteeReferred to Rules Committee · House Rules
  4. CommitteeAssigned to Prescription Drug Affordability & Accessibility Committee · House Prescription Drug Affordability
  5. CommitteeRule 19(a) / Re-referred to Rules Committee · House Rules
  6. HouseChief Sponsor Changed to Rep. Jenn Ladisch Douglass
  7. CommitteeAssigned to Health Care Availability & Accessibility Committee · House Health Care Availability & Access
  8. HouseFiscal Note Requested by Rep. Jackie Haas
  9. HouseFiscal Note Filed
  10. CommitteeRule 19(a) / Re-referred to Rules Committee · House Rules
  11. HouseSession Sine Die

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

From Illinois's official records (www.ilga.gov), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.